| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.06. | Karyopharm Therapeutics Inc.: Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates | 152 | PR Newswire | Long-Term Follow-Up Data Signal Promising Progression-Free Survival (PFS) for Selinexor in the Maintenance Setting with Median PFS of 28.4 Months in the TP53 Wild-Type and 39.5 Months in the Proficient... ► Artikel lesen | |
| 01.06. | CStone Pharmaceuticals: CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC | 89 | PR Newswire | EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival (OS) benefits of sugemalimab... ► Artikel lesen | |
| 01.06. | Hyundai Motor America Reports May 2024 Sales | 102 | PR Newswire | Total sales up 12% in May; YTD total sales increase 2%
Best May for IONIQ 5, IONIQ 6, Tucson HEV, Santa Fe HEV, Palisade and Santa Cruz
Hyundai May retail sales up 9% YOY; Volume led by Palisade... ► Artikel lesen | |
| 01.06. | Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 | 95 | PR Newswire | Zanidatamab demonstrated a median overall survival (OS) of 15.5 months in patients with centrally confirmed immunohistochemistry (IHC) 2+ or 3+ and a median OS of 18.1 months in patients with IHC 3+... ► Artikel lesen | |
| 01.06. | TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meeting | 18 | PR Newswire | Poster presentation features the interim data from an ongoing Phase 1b clinical trial of TU2218 plus Keytruda combination therapy in patients with advanced solid tumors
A 40% overall response rate... ► Artikel lesen | |
| 01.06. | Eli Lilly and Company: Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO Annual Meeting | 100 | PR Newswire | Data demonstrated promising monotherapy activity with olomorasib across a range of KRAS G12C-mutant solid tumors, including non-small cell lung cancer, and a tolerability profile in combination with... ► Artikel lesen | |
| 01.06. | Akeso, Inc.: Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy | 98 | PR Newswire | Separate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Statistically Significant Benefit: PFS Hazard Ratio of 0.46
For Subset of Patients Previously Receiving... ► Artikel lesen | |
| 01.06. | GDToday: Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US | 842 | PR Newswire | GUANGZHOU, China, June 1, 2024 /PRNewswire/ -- A news report from GDToday:
Organized by the Guangdong Government, the Government of the State of California, Chinese People's for Friendship... ► Artikel lesen | |
| 01.06. | CStone Pharmaceuticals: CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC | 877 | PR Newswire | EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival (OS) benefits of... ► Artikel lesen | |
| 01.06. | KIA America, Inc.: All-time Best Monthly Sales For The Kia Ev9 And Sportage Suvs Lead Kia America To Second Best Sales Month In Company History In May | 604 | PR Newswire | Sales of the all-electric EV9 three-row SUV increased for the second straight month, leading to Kia's highest EV monthly sales in history
Sportage, Telluride, Carnival, EV6 and Niro hit all-time sales... ► Artikel lesen | |
| 01.06. | ZEEKR Intelligent Technology Holding Limited: ZEEKR Announces May 2024 Delivery Update | 884 | PR Newswire | HANGZHOU, China, June 1, 2024 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("ZEEKR" or the "Company") (NYSE: ZK), a fast-growing intelligent battery electric vehicle ("BEV") technology... ► Artikel lesen | |
| 01.06. | Numinus Wellness Inc.: Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders | 215 | PR Newswire | VANCOUVER, BC, May 31, 2024 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral... ► Artikel lesen | |
| 01.06. | Gogoro Inc: Gogoro Announces Results of Annual General Meeting of Shareholders | 197 | PR Newswire | TAIPEI, May 31, 2024 /PRNewswire/ -- Gogoro Inc. ("Gogoro" or the "Company") (Nasdaq: GGR), a global technology leader in battery swapping ecosystems that enable sustainable mobility solutions... ► Artikel lesen | |
| 01.06. | ROCKSTAR ENERGY DRINK® AND RUDIMENTAL MARK RETURN OF FRIDAY NIGHT SHOW WITH LEGENDARY PERFORMANCE | 874 | PR Newswire | Rockstar Energy Drink and UEFA have set the stage for the UEFA Champions League final weekend with a headline performance by Rudimental, powered partly with kinetic energy generated from... ► Artikel lesen | |
| 01.06. | Huobi Technology PTE. LTD.: HTX Ventures Invests in Babylon to Advance Trustless Bitcoin Staking | 611 | PR Newswire | SINGAPORE, June 1, 2024 /PRNewswire/ -- HTX Ventures, the global investment arm of the cryptocurrency exchange HTX, has announced a strategic investment in Babylon, a Bitcoin staking protocol.... ► Artikel lesen | |
| 01.06. | RECOMMENDED CASH OFFER for MARIADB PLC by MERIDIAN BIDCO LLC ("Bidco") which is an Affiliate of K1 INVESTMENT MANAGEMENT, LLC ("K1") as manager of K5 PRIVATE INVESTORS, L.P. | 802 | PR Newswire | ANNOUNCEMENT REGARDING RULE 15 PROPOSALS
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 9.413 |
| EVOTEC | 4.653 |
| BAYER | 3.712 |
| SUPER MICRO COMPUTER | 3.617 |
| NEL | 3.301 |
| MICROSTRATEGY | 2.014 |
| RHEINMETALL | 1.854 |
| TUI | 1.564 |
| TESLA | 1.495 |
| THYSSENKRUPP | 1.308 |
| PALANTIR TECHNOLOGIES | 1.268 |
| PORSCHE AG | 1.260 |
| VOLKSWAGEN | 1.105 |
| RENK GROUP | 1.068 |
| BIONTECH | 1.064 |
| COINBASE GLOBAL | 913 |
| GAMESTOP | 877 |
| AIXTRON SE | 838 |
| COMMERZBANK | 818 |
| DEUTSCHE BANK | 797 |
| AMAZON | 767 |
| MERCEDES-BENZ | 767 |
| BYD | 764 |
| SNOWFLAKE | 764 |
| BASF | 745 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
